Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain

The conversion of the normal form of prion protein (PrPC) to a disease-specific form (PrPSc) is a central event in scrapie and other transmissible spongiform encephalopathies. PrPSc is distinguished from PrPC by its insolubility and its resistance to proteolysis. PrPSc is also capable of converting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 1996-10, Vol.35 (41), p.13434-13442
Hauptverfasser: Kocisko, David A, Lansbury, Peter T, Caughey, Byron
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 13442
container_issue 41
container_start_page 13434
container_title Biochemistry (Easton)
container_volume 35
creator Kocisko, David A
Lansbury, Peter T
Caughey, Byron
description The conversion of the normal form of prion protein (PrPC) to a disease-specific form (PrPSc) is a central event in scrapie and other transmissible spongiform encephalopathies. PrPSc is distinguished from PrPC by its insolubility and its resistance to proteolysis. PrPSc is also capable of converting 35S-PrPC, in vitro, into a form which is indistinguishable from PrPSc with respect to its protease-sensitivity. Both the “converting activity” and the protease-resistance of isolated hamster PrPSc can be at least partially eliminated by denaturation and recovered by renaturation, provided that the concentration of denaturant does not exceed a threshhold. This study was undertaken in order to localize the regions of native PrPSc structure that must remain intact to allow refolding. Proteinase K was used to digest exposed, denatured PrPSc sequences, and the residual fragments were characterized using anti-PrP antibodies directed toward four PrP epitopes. A 16-kDa fragment marked by an epitope within residues 143−156 remained protease-resistant under conditions which at least partially unfolded epitopes within residues 90−115 and 217−232. However, dilution of denaturant restored protease-resistance to these epitopes. This reversible unfolding was observed with both purified PrPSc and PrPSc in crude brain homogenates. Size fractionation of partially GdnHCl-solubilized PrPSc revealed that only the insoluble aggregates retained the ability to refold, consistent with the hypothesis that native PrPSc is an ordered aggregate. When the threshold denaturant concentration was exceeded, both protease-resistance of the 16-kDa C-terminal domain and converting activity were irreversibly destroyed. These results suggest that the in vitro converting activity requires ordered, protease-resistant PrPSc aggregates and that a critical aspect of the PrPSc structure is the folding of a particularly stable ∼16-kDa C-terminal domain.
doi_str_mv 10.1021/bi9610562
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78449460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15780594</sourcerecordid><originalsourceid>FETCH-LOGICAL-a445t-9eaae9615cdef0afee840d0980a6a957b38e357619c9f6b3008ec53091c7dc563</originalsourceid><addsrcrecordid>eNqFkc9uEzEQxi1EVULhwAMg7QUkDgvjXf_lVtIGWlUiounZcryzyO2uHewNKjeuvCZPUqOEnJC4zOjz99M38gwhLyi8pdDQd2uvBQUumkdkRnkDNdOaPyYzABB1owU8IU9zvi2SgWTH5Fgp2QrazMj90qbJ26G6CX0cOh--VjZ01Rf8q2JfXbtkNx7r05yj83bCrlomH0OpcUIf3v_--as6_-47DA6rPqbKVvPkJ-9KLhX13VnR9QrT6EN5OYuj9eEZOertkPH5vp-Qm8X5av6pvvr88WJ-elVbxvhUa7QWy-e467AH2yMqBh1oBVZYzeW6VdhyKah2uhfrFkCh4y1o6mTnuGhPyOtd7ibFb1vMkxl9djgMNmDcZiMVY5oJ-C9IuVTANSvgmx3oUsw5YW82yY82_TAUzJ9zmMM5CvtyH7pdj9gdyP3-i1_vfJ8nvD_YNt0ZIVvJzWp5bZS4bBdUfjCLwr_a8dZlcxu3qSw0_2PuA_oZn38</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15780594</pqid></control><display><type>article</type><title>Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain</title><source>MEDLINE</source><source>ACS Publications</source><creator>Kocisko, David A ; Lansbury, Peter T ; Caughey, Byron</creator><creatorcontrib>Kocisko, David A ; Lansbury, Peter T ; Caughey, Byron</creatorcontrib><description>The conversion of the normal form of prion protein (PrPC) to a disease-specific form (PrPSc) is a central event in scrapie and other transmissible spongiform encephalopathies. PrPSc is distinguished from PrPC by its insolubility and its resistance to proteolysis. PrPSc is also capable of converting 35S-PrPC, in vitro, into a form which is indistinguishable from PrPSc with respect to its protease-sensitivity. Both the “converting activity” and the protease-resistance of isolated hamster PrPSc can be at least partially eliminated by denaturation and recovered by renaturation, provided that the concentration of denaturant does not exceed a threshhold. This study was undertaken in order to localize the regions of native PrPSc structure that must remain intact to allow refolding. Proteinase K was used to digest exposed, denatured PrPSc sequences, and the residual fragments were characterized using anti-PrP antibodies directed toward four PrP epitopes. A 16-kDa fragment marked by an epitope within residues 143−156 remained protease-resistant under conditions which at least partially unfolded epitopes within residues 90−115 and 217−232. However, dilution of denaturant restored protease-resistance to these epitopes. This reversible unfolding was observed with both purified PrPSc and PrPSc in crude brain homogenates. Size fractionation of partially GdnHCl-solubilized PrPSc revealed that only the insoluble aggregates retained the ability to refold, consistent with the hypothesis that native PrPSc is an ordered aggregate. When the threshold denaturant concentration was exceeded, both protease-resistance of the 16-kDa C-terminal domain and converting activity were irreversibly destroyed. These results suggest that the in vitro converting activity requires ordered, protease-resistant PrPSc aggregates and that a critical aspect of the PrPSc structure is the folding of a particularly stable ∼16-kDa C-terminal domain.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi9610562</identifier><identifier>PMID: 8873612</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Cricetinae ; Endopeptidase K ; Guanidine ; Guanidines - pharmacology ; In Vitro Techniques ; Mesocricetus ; Molecular Structure ; Molecular Weight ; Protein Conformation - drug effects ; Protein Denaturation ; Protein Folding ; PrP 27-30 Protein - chemistry ; PrPSc Proteins - chemistry ; Scrapie - etiology ; Scrapie - metabolism</subject><ispartof>Biochemistry (Easton), 1996-10, Vol.35 (41), p.13434-13442</ispartof><rights>Copyright © 1996 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a445t-9eaae9615cdef0afee840d0980a6a957b38e357619c9f6b3008ec53091c7dc563</citedby><cites>FETCH-LOGICAL-a445t-9eaae9615cdef0afee840d0980a6a957b38e357619c9f6b3008ec53091c7dc563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi9610562$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi9610562$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,782,786,2767,27083,27931,27932,56745,56795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8873612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kocisko, David A</creatorcontrib><creatorcontrib>Lansbury, Peter T</creatorcontrib><creatorcontrib>Caughey, Byron</creatorcontrib><title>Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>The conversion of the normal form of prion protein (PrPC) to a disease-specific form (PrPSc) is a central event in scrapie and other transmissible spongiform encephalopathies. PrPSc is distinguished from PrPC by its insolubility and its resistance to proteolysis. PrPSc is also capable of converting 35S-PrPC, in vitro, into a form which is indistinguishable from PrPSc with respect to its protease-sensitivity. Both the “converting activity” and the protease-resistance of isolated hamster PrPSc can be at least partially eliminated by denaturation and recovered by renaturation, provided that the concentration of denaturant does not exceed a threshhold. This study was undertaken in order to localize the regions of native PrPSc structure that must remain intact to allow refolding. Proteinase K was used to digest exposed, denatured PrPSc sequences, and the residual fragments were characterized using anti-PrP antibodies directed toward four PrP epitopes. A 16-kDa fragment marked by an epitope within residues 143−156 remained protease-resistant under conditions which at least partially unfolded epitopes within residues 90−115 and 217−232. However, dilution of denaturant restored protease-resistance to these epitopes. This reversible unfolding was observed with both purified PrPSc and PrPSc in crude brain homogenates. Size fractionation of partially GdnHCl-solubilized PrPSc revealed that only the insoluble aggregates retained the ability to refold, consistent with the hypothesis that native PrPSc is an ordered aggregate. When the threshold denaturant concentration was exceeded, both protease-resistance of the 16-kDa C-terminal domain and converting activity were irreversibly destroyed. These results suggest that the in vitro converting activity requires ordered, protease-resistant PrPSc aggregates and that a critical aspect of the PrPSc structure is the folding of a particularly stable ∼16-kDa C-terminal domain.</description><subject>Animals</subject><subject>Cricetinae</subject><subject>Endopeptidase K</subject><subject>Guanidine</subject><subject>Guanidines - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Mesocricetus</subject><subject>Molecular Structure</subject><subject>Molecular Weight</subject><subject>Protein Conformation - drug effects</subject><subject>Protein Denaturation</subject><subject>Protein Folding</subject><subject>PrP 27-30 Protein - chemistry</subject><subject>PrPSc Proteins - chemistry</subject><subject>Scrapie - etiology</subject><subject>Scrapie - metabolism</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9uEzEQxi1EVULhwAMg7QUkDgvjXf_lVtIGWlUiounZcryzyO2uHewNKjeuvCZPUqOEnJC4zOjz99M38gwhLyi8pdDQd2uvBQUumkdkRnkDNdOaPyYzABB1owU8IU9zvi2SgWTH5Fgp2QrazMj90qbJ26G6CX0cOh--VjZ01Rf8q2JfXbtkNx7r05yj83bCrlomH0OpcUIf3v_--as6_-47DA6rPqbKVvPkJ-9KLhX13VnR9QrT6EN5OYuj9eEZOertkPH5vp-Qm8X5av6pvvr88WJ-elVbxvhUa7QWy-e467AH2yMqBh1oBVZYzeW6VdhyKah2uhfrFkCh4y1o6mTnuGhPyOtd7ibFb1vMkxl9djgMNmDcZiMVY5oJ-C9IuVTANSvgmx3oUsw5YW82yY82_TAUzJ9zmMM5CvtyH7pdj9gdyP3-i1_vfJ8nvD_YNt0ZIVvJzWp5bZS4bBdUfjCLwr_a8dZlcxu3qSw0_2PuA_oZn38</recordid><startdate>19961015</startdate><enddate>19961015</enddate><creator>Kocisko, David A</creator><creator>Lansbury, Peter T</creator><creator>Caughey, Byron</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19961015</creationdate><title>Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain</title><author>Kocisko, David A ; Lansbury, Peter T ; Caughey, Byron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a445t-9eaae9615cdef0afee840d0980a6a957b38e357619c9f6b3008ec53091c7dc563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Cricetinae</topic><topic>Endopeptidase K</topic><topic>Guanidine</topic><topic>Guanidines - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Mesocricetus</topic><topic>Molecular Structure</topic><topic>Molecular Weight</topic><topic>Protein Conformation - drug effects</topic><topic>Protein Denaturation</topic><topic>Protein Folding</topic><topic>PrP 27-30 Protein - chemistry</topic><topic>PrPSc Proteins - chemistry</topic><topic>Scrapie - etiology</topic><topic>Scrapie - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kocisko, David A</creatorcontrib><creatorcontrib>Lansbury, Peter T</creatorcontrib><creatorcontrib>Caughey, Byron</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kocisko, David A</au><au>Lansbury, Peter T</au><au>Caughey, Byron</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>1996-10-15</date><risdate>1996</risdate><volume>35</volume><issue>41</issue><spage>13434</spage><epage>13442</epage><pages>13434-13442</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>The conversion of the normal form of prion protein (PrPC) to a disease-specific form (PrPSc) is a central event in scrapie and other transmissible spongiform encephalopathies. PrPSc is distinguished from PrPC by its insolubility and its resistance to proteolysis. PrPSc is also capable of converting 35S-PrPC, in vitro, into a form which is indistinguishable from PrPSc with respect to its protease-sensitivity. Both the “converting activity” and the protease-resistance of isolated hamster PrPSc can be at least partially eliminated by denaturation and recovered by renaturation, provided that the concentration of denaturant does not exceed a threshhold. This study was undertaken in order to localize the regions of native PrPSc structure that must remain intact to allow refolding. Proteinase K was used to digest exposed, denatured PrPSc sequences, and the residual fragments were characterized using anti-PrP antibodies directed toward four PrP epitopes. A 16-kDa fragment marked by an epitope within residues 143−156 remained protease-resistant under conditions which at least partially unfolded epitopes within residues 90−115 and 217−232. However, dilution of denaturant restored protease-resistance to these epitopes. This reversible unfolding was observed with both purified PrPSc and PrPSc in crude brain homogenates. Size fractionation of partially GdnHCl-solubilized PrPSc revealed that only the insoluble aggregates retained the ability to refold, consistent with the hypothesis that native PrPSc is an ordered aggregate. When the threshold denaturant concentration was exceeded, both protease-resistance of the 16-kDa C-terminal domain and converting activity were irreversibly destroyed. These results suggest that the in vitro converting activity requires ordered, protease-resistant PrPSc aggregates and that a critical aspect of the PrPSc structure is the folding of a particularly stable ∼16-kDa C-terminal domain.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>8873612</pmid><doi>10.1021/bi9610562</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 1996-10, Vol.35 (41), p.13434-13442
issn 0006-2960
1520-4995
language eng
recordid cdi_proquest_miscellaneous_78449460
source MEDLINE; ACS Publications
subjects Animals
Cricetinae
Endopeptidase K
Guanidine
Guanidines - pharmacology
In Vitro Techniques
Mesocricetus
Molecular Structure
Molecular Weight
Protein Conformation - drug effects
Protein Denaturation
Protein Folding
PrP 27-30 Protein - chemistry
PrPSc Proteins - chemistry
Scrapie - etiology
Scrapie - metabolism
title Partial Unfolding and Refolding of Scrapie-Associated Prion Protein:  Evidence for a Critical 16-kDa C-Terminal Domain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T01%3A45%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20Unfolding%20and%20Refolding%20of%20Scrapie-Associated%20Prion%20Protein:%E2%80%89%20Evidence%20for%20a%20Critical%2016-kDa%20C-Terminal%20Domain&rft.jtitle=Biochemistry%20(Easton)&rft.au=Kocisko,%20David%20A&rft.date=1996-10-15&rft.volume=35&rft.issue=41&rft.spage=13434&rft.epage=13442&rft.pages=13434-13442&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi9610562&rft_dat=%3Cproquest_cross%3E15780594%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15780594&rft_id=info:pmid/8873612&rfr_iscdi=true